Eli Lilly and Company Clinical Trial Registry

Eli Lilly and Company is committed to meeting patient needs through innovative medicine and clinical excellence. As part of the development process for medicines, Eli Lilly and Company conducts research to help determine safety and efficacy of various test medications; and conducts research with the intent of learning more about treatment options, disease states, diagnostics, and other associated issues that contribute to the health and well being of patients. This research often occurs in the form of clinical trials and observational / non-interventional studies. This information may, or may not, relate to uses that have been studied and approved by various regulatory agencies around the world. The information contained in this site is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of Lilly medicines.

Since the time of Lilly's voluntary establishment of lillytrials.com in 2004, evolving international standards and U.S. state and federal regulations have necessitated modifications to the specific content, form and locations by which Lilly communicates its disclosure of study initiation and study results. At this time, Lilly provides some of these disclosures directly on this website while others are displayed on external third party websites which are linked to from this website.

Also note that clinical trials and observational / non-interventional studies on Lilly products may also be sponsored and reported parties other than Lilly in other clinical trial registries.

This site contains information and links to information about clinical studies sponsored by Eli Lilly and Company. This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, please consult a physician.

This site contains results and links to results from individual trials/studies only. There are many factors beyond individual trial/study results that must be considered in order to determine whether a drug is safe, effective, or appropriate for a particular use. When making prescribing decisions, physicians should always refer to the specific labeling information approved for the patient's country or region.